Tackling the New Bottleneck of Drug Discovery

Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.

Markus Gershater is the Chief Scientific Officer and co-founder of Synthace, a company pioneering the integration of digital technology into the experimental research process. With a PhD in plant biochemistry from Durham University, Markus has a deep understanding of biological complexity and how to effectively address it to engineer biology and biological processes. His expertise spans robust, transferable protocols, flexible automation, and sophisticated experimental design and data analysis.